Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.
about
Cardiac cachexia: hic et nuncFrailty in Advanced Heart Failure: A Consequence of Aging or a Separate Entity?ASK1 associates with troponin T and induces troponin T phosphorylation and contractile dysfunction in cardiomyocytesTumor necrosis factor receptor levels are associated with carotid atherosclerosisIncreased circulating cytokines in patients with myocarditis and cardiomyopathy.Biologics and heart failure in rheumatoid arthritis: are we any wiser?Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.Heart failure as a metabolic problem.Recent advances in the management of chronic heart failure.Risk of cardiovascular disease in inflammatory bowel disease.Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietinActivation of cytokines as a mechanism of disease progression in heart failureNeopterin and beta-2 microglobulin relations to immunity and inflammatory status in nonischemic dilated cardiomyopathy patientsApoptosis and changes in contractile protein pattern in the skeletal muscle in heart failure.Down-regulation of MyoD gene expression in rat diaphragm muscle with heart failure.Heart failure in 10 years time: focus on pharmacological treatment.Therapeutic inhibition of tumour necrosis factor alpha in patients with heart failure: cooling an inflamed heart.Assessment of endothelial damage and dysfunction: observations in relation to heart failure.The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure.Tumour necrosis factor alpha gene polymorphism: a predisposing factor to non-ischaemic myocardial dysfunction?Cardiac cachexia.The prognostic value of anemia, right-heart catheterization and neurohormones in chronic heart failure.The levels of Ghrelin, TNF-alpha, and IL-6 in children with cyanotic and acyanotic congenital heart disease.Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis.Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy.Psoriasis comorbidities: complications and benefits of immunobiological treatmentsTNF-R Levels: Apical Periodontitis Linked to Coronary Heart Disease.Relationship between site of myocardial infarction, left ventricular function and cytokine levels in patients undergoing coronary artery surgery.Toll-like receptors: new players in myocardial ischemia/reperfusion injury.When are pro-inflammatory cytokines SAFE in heart failure?Serum levels of ghrelin, tumor necrosis factor-alpha and interleukin-6 in infants and children with congenital heart disease.The treatment of heart failure--what next?Impaired leukotriene C4 generation in granulocytes from protein-energy malnourished chronically ill elderly.Endogenous nitric oxide in cardiovascular disease and transplantation.Sudden cardiac death in patients with rheumatoid arthritisImmune modulation of cardiac cell function.Mechanism of cardioprotective action of TNF-alpha in the isolated rat heart.Tumour necrosis factor alpha in severe congestive cardiac failure.Effect of thalidomide on the skeletal muscle in experimental heart failure.
P2860
Q26744140-E977ECA0-0FCB-40B9-8B15-BFB6CD0AB33DQ26798517-839A8549-E350-43E1-9AB3-F0ACF2264846Q28180984-F8AF19E0-C371-49A8-84B7-52E9AE7733CAQ28344629-8FECDACD-E01F-4E60-92AF-93DEC07A3B14Q33614427-AA1A5D16-2F0E-47F5-96CE-02813C0938D7Q33898103-E2EF6B77-59D7-4968-AD67-E30BC7A39A5AQ33907789-6F09AE1D-9FD5-404E-B6A8-FCE312984437Q33999696-8B20C103-BAE9-4F56-9A27-F8A0D712F7FEQ34031741-CFCCC77A-2DF6-4641-8889-C617810203F4Q34048041-97AB3078-FB9E-4E46-B597-5CDBCC4877D3Q34069738-793C7DF9-C5D6-4E63-BE6D-F13006F7A820Q34071319-39F31463-E6B3-43B8-8230-80B5D6FF11AFQ34118314-916CCFC5-299E-4A42-8E65-97493BE168ADQ34285835-ECEC426A-6FB2-4BA0-B453-7BA2DBCC86CFQ34656253-AE60A466-1C95-403A-A106-2991058F17B5Q34817094-8C61E5FE-4C2E-40D4-8004-F42369970532Q35026157-A041BCF6-B3E7-4E59-BD87-89F5B8304ABDQ35090254-8ABD329F-5612-45E5-9C80-A4DD4EB86C9FQ35135831-2D8C3955-DD98-4374-9AEB-DCF0F7197E25Q35373849-D7225872-B963-489E-BD3C-D9464A0936DCQ35579705-71A1A605-042D-40DC-9A4D-195BC2F7D458Q35932382-EE4E74C8-D54B-4B70-A398-95DC1393D8FCQ36352015-C0FB3A85-5DAE-4F80-871D-285BE0906133Q36417549-4BD00882-6F1D-4C9C-B154-B73CB322C8FEQ36836922-34A25607-3B36-4A1D-9071-83E5324AEA53Q37464185-167F704E-0827-4028-93A2-DDF0AA83377DQ37540440-991BCFB1-E2AE-4043-B292-BD3600C8635AQ37658778-AEEA7698-1E7B-422B-B228-0777B644B8A1Q37726127-AAEC52A5-D475-4923-92D6-54D528BE4D77Q37810952-A8458B54-5B61-4707-8925-88645AC09F0DQ37838085-10E3ECDA-15EC-40DC-BAB4-0F258CA4FAFDQ38861700-DF4589BE-FF0F-4E97-A6C1-761BE983FEBAQ39493510-B380171A-E3F2-449D-88C4-01571E1C0476Q39541210-2025820B-7941-4D08-96D1-589274DF2E5CQ40405195-10AD2AA3-6A7D-4CA3-AD0F-103A1973F4C1Q41264898-B8B89832-81AC-4B8E-8A6F-C5FDC69EC75EQ42077100-655229F9-5812-4454-A9D5-62B3D6E1A386Q42162225-AB712EE0-93C1-4BD0-B614-61B2DC5D5CC5Q42578275-DE6F71E5-9682-47D3-A32A-A64E9E572FCBQ44094091-79F3722E-DA2F-446E-A8E2-96491F9A5C91
P2860
Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.
description
1991 nî lūn-bûn
@nan
1991 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Increased concentrations of tu ...... severe chronic heart failure.
@ast
Increased concentrations of tu ...... severe chronic heart failure.
@en
type
label
Increased concentrations of tu ...... severe chronic heart failure.
@ast
Increased concentrations of tu ...... severe chronic heart failure.
@en
prefLabel
Increased concentrations of tu ...... severe chronic heart failure.
@ast
Increased concentrations of tu ...... severe chronic heart failure.
@en
P2093
P2860
P356
P1476
Increased concentrations of tu ...... severe chronic heart failure.
@en
P2093
P2860
P304
P356
10.1136/HRT.66.5.356
P577
1991-11-01T00:00:00Z